Sublobar resection in high-risk patients for lobectomy: current and future strategy

Abstract

Surgical resection by lobectomy is the gold standard of therapy for early stage non-small cell lung cancer. However, not all patients are medically fit to undergo surgery. In patients considered high-risk for lobectomy, alternative strategies have been developed including radiofrequency ablation, cryoablation, microwave ablation, stereotactic radiation therapy, wedge resection, and segmentectomy. This work reviews the definition of high-risk, and the outcomes that have been associated with each treatment technique. Some technical points regarding wedge resection versus segmentectomy are noted. Future directions are discussed in the context of treatment for patients considered at high-risk for lobectomy.

Keywords

Non-small cell lung cancer / sublobar resection / surgical technique / high-risk patients

References

[1] Fernando HC,Mandrekar SJ.The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial..J Thorac Cardiovasc Surg2011;142:554-62 PMCID:PMC3156868

[2] Puri V,Bell JM.National cooperative group trials of “high-risk” patients with lung cancer: are they truly “high-risk”?.Ann Thorac Surg2014;97:1678-83 PMCID:PMC4045623

[3] National Comprehensive Cancer Network. Non-Small Cell Lung Cancer (Version 7.2020) Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf [Last accessed on 18 Dec 2020.]

[4] Fernando HC,Mandrekar SJ.Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study..J Thorac Cardiovasc Surg2011;142:1143-51 PMCID:PMC3199353

[5] Kent M,Mandrekar S.Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients..Ann Thorac Surg2013;96:1747-54

[6] Sancheti MS,Medbery RL.Outcomes after surgery in high-risk patients with early stage lung cancer..Ann Thorac Surg2016;101:1043-50

[7] Ginsberg RJ.Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer..Ann Thorac Surg1995;60:615-22

[8] Fernando HC,Landreneau RJ.Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates..J Thorac Cardiovasc Surg2005;129:639-44

[9] Zhong L,Shi J.Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation..J Thorac Dis2017;9:590-7 PMCID:PMC5394077

[10] Wang H,Duan Y,Feng H.Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures..Radiology2005;235:289-98

[11] Simon CJ,DiPetrillo TA.Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients..Radiology2007;243:268-75

[12] Lam A,Bui K,Nelson K.A national cancer database analysis of radiofrequency ablation versus stereotactic body radiotherapy in early-stage non-small cell lung cancer..J Vasc Interv Radiol2018;29:1211-7

[13] Zhao H.Long-term outcome following microwave ablation of early-stage non-small cell lung cancer..J Med Imaging Radiat Oncol2020;64:787-93

[14] Yuan Z,Zhang J,Li W.A meta-analysis of clinical outcomes after radiofrequency ablation and microwave ablation for lung cancer and pulmonary metastases..J Am Coll Radiol2019;16:302-14

[15] Inoue M,Jinzaki M.Cryoablation of early-stage primary lung cancer..Biomed Res Int2014;2014:521691 PMCID:PMC4065703

[16] Zhang YS,Zhan K.Percutaneous imaging-guided cryoablation for lung cancer..J Thorac Dis2016;8:S705-9 PMCID:PMC5179355

[17] Yamauchi Y,Hashimoto K.Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer..PLoS One2012;7:e33223 PMCID:PMC3297638

[18] Moore W,Bhattacharji P.Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients..J Vasc Interv Radiol2015;26:312-9

[19] Zemlyak A,Bilfinger TV.Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer..J Am Coll Surg2010;211:68-72

[20] Videtic GMM,Giuliani M.Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline..Pract Radiat Oncol2017;7:295-301

[21] Videtic GM,Singh AK.A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927)..Int J Radiat Oncol Biol Phys2015;93:757-64 PMCID:PMC4744654

[22] Videtic GM,Singh AK.Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer..Int J Radiat Oncol Biol Phys2019;103:1077-84 PMCID:PMC6454873

[23] Bi N,Zheng X.Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage i non-small cell lung cancer: a systemic review and pooled analysis..Int J Radiat Oncol Biol Phys2016;95:1378-90 PMCID:PMC6483384

[24] Ager BJ,Gruhl JD.Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer..Lung Cancer2019;138:6-12 PMCID:PMC7082035

[25] Chi A,Sun Y.Comparison of long-term survival of patients with early-stage non-small cell lung cancer after surgery vs stereotactic body radiotherapy..JAMA Netw Open2019;2:e1915724 PMCID:PMC6902813

[26] Jensik RJ,Milloy FJ.Segmental resection for lung cancer. A fifteen-year experience..J Thorac Cardiovasc Surg1973;66:563-72

[27] Altorki NK,Hanaoka T.Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules..J Thorac Cardiovasc Surg2014;147:754-62

[28] Ijsseldijk MA,Siegert C.Oncologic outcomes of surgery versus sbrt for non-small-cell lung carcinoma: a systematic review and meta-analysis..Clin Lung Cancer2020;S1525-7304(20)30140-6

[29] Hou B,Zhou D,Dai JG.Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis..Ther Adv Respir Dis2016;10:435-43 PMCID:PMC5933623

[30] Suzuki K,Aokage K.Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial..J Thorac Cardiovasc Surg2019;158:895-907

[31] Altorki NK,Wigle D.Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)..Lancet Respir Med2018;6:915-24 PMCID:PMC6396275

[32] Stamatis G,Schwarz B.Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)..Lung Cancer2019;138:19-26

[33] Shapiro M,Wisnivesky JP,Arustamyan M.Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer..J Thorac Cardiovasc Surg2009;137:1388-93

[34] Bilgi Z.Current indications and outcomes for thoracoscopic segmentectomy for early stage lung cancer..J Thorac Dis2019;11:S1662-9 PMCID:PMC6706620

[35] McKenna RJ,Swanson SJ.Atlas of minimally invasive thoracic surgery (VATS).2011;1st edPhiladelphiaElsevier

[36] Mohiuddin K,Sofer T.Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤ 2 cm) non-small cell lung cancer..J Thorac Cardiovasc Surg2014;147:1169-75

[37] Khullar OV,Gillespie T.Survival after sublobar resection versus lobectomy for clinical stage ia lung cancer: an analysis from the national cancer data base..J Thorac Oncol2015;10:1625-33 PMCID:PMC5798611

[38] Wolf AS,Yip R.The impact of margins on outcomes after wedge resection for stage i non-small cell lung cancer..Ann Thorac Surg2017;104:1171-8

[39] Hassani C,Nieva J.Radiomics in pulmonary lesion imaging..AJR Am J Roentgenol2019;212:497-504

[40] Wu W,Grossmann P.Exploratory Study to identify radiomics classifiers for lung cancer histology..Front Oncol2016;6:71 PMCID:PMC4811956

[41] Liu Y,Balagurunathan Y.Radiomic features are associated with egfr mutation status in lung adenocarcinomas..Clin Lung Cancer2016;17:441-8 PMCID:PMC5548419

[42] Vaidya P,Gupta A.CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction..The Lancet Digital Health2020;2:e116-28 PMCID:PMC7051021

[43] Gill RR,Jaklitsch MT,Hartigan PM.Image-guided video-assisted thoracoscopic resection (iVATS): translation to clinical practice-real-world experience..J Surg Oncol.2020;121:1225-32 PMCID:PMC7383497

[44] Huynh E,Narayan V.Associations of radiomic data extracted from static and respiratory-gated CT scans with disease recurrence in lung cancer patients treated with SBRT..PLoS One2017;12:e0169172 PMCID:PMC5207741

[45] Mattonen SA,Johnson C.Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: physician performance versus radiomic assessment..Int J Radiat Oncol Biol Phys2016;94:1121-8

[46] Gill RR,Jaklitsch MT,Hartigan PM.Image-guided video-assisted thoracoscopic resection (iVATS): translation to clinical practice-real-world experience..J Surg Oncol2020;121:1225-32 PMCID:PMC7383497

[47] Chao YK,Wen CT.Image-guided thoracoscopic lung resection using a dual-marker localization technique in a hybrid operating room..Surg Endosc2019;33:3858-63

[48] Wen CT,Fang HY,Chao YK.Image-guided video-assisted thoracoscopic small lung tumor resection using near-infrared marking..Surg Endosc2018;32:4673-80